Send feedback

OSBPL2 p.Phe270=

c.810T>C · rs761549244 · VCV737946

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0127%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -2GERP -5
Overall
CADD6.749PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0127% European (non-Finnish) · 150/1,178,324 alleles
Filtering AF 0.0111% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0104%
Overall 0.00999% 161/1,612,078 alleles · ultra-rare exomes 139/1,459,808 · genomes 22/152,270 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0127% 7,856
African / African-American 0.0107% 9,367
Remaining individualsnot grpmax-eligible 0.00481% 20,805

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
OSBPL2
Protein
p.Phe270=
Coding
c.810T>C
MANE Select
NM_144498
dbSNP
rs761549244
Type
single nucleotide variant
Location
chr20:62281817 (GRCh38)
Gene constraint
LOEUF 0.467 · pLI 1.00 · ClinGen HI 1/3 (gnomAD)
Structure
AlphaFold pLDDT 83.92 · 1 PDB
Residue 270
a β-strand
Full OSBPL2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/osbpl2-p-phe270 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown